Research peptide · LY3298176
Tirzepatide 60mg, GIP/GLP-1 dual-agonist research peptide. Lyophilized powder, ≥99% HPLC purity, batch-traceable, CoA included. Worldwide shipping.
hatte davor das selbe bei einem anderen shop geholt aber spüre hier mehr
/ vial
Independently verified quality
3,000+
satisfied researchers
99.43%
Avg. purity 2026
4.8 ★
ProvenExpert
Tirazeptid is a synthetic dual agonist that simultaneously targets GIP and GLP-1 receptors. Available as a 60mg vial in lyophilized powder form with complete batch documentation. Each vial contains high-purity peptide verified by HPLC analysis. Store refrigerated at 2–8°C for optimal stability.
GLP-1R and GIPR dual agonism: glucose-dependent insulin secretion, appetite suppression via hypothalamic satiety circuits, improved insulin sensitivity in adipose tissue, brown adipose tissue activation via GIPR
Beginner protocol
2.5 mg / Woche
Advanced protocol
2,5–15 mg/Woche (Forschungskontext)
Note: The dosages listed correspond to typical ranges from published research literature. They do not replace advice from a qualified researcher or physician.
Every batch is analyzed by an independent laboratory via HPLC before shipment. We document purity (avg. 99.43% in 2026), mass spectrometry identity, and sterility. Production follows GMP standards in ISO-certified laboratories.
Tirzepatid is currently available as a 60mg vial. Further dosages will be added soon.
Tirzepatid acts simultaneously on two receptors: GIP and GLP-1. This dual action distinguishes it from pure GLP-1 agonists such as Semaglutide.
Store lyophilized powder in a cool place at 2–8°C. After reconstitution, store refrigerated and use promptly.
>=99% purity, verified via HPLC analysis. Certificate of Analysis is included.
Yes, with 2 vials you save €10 per vial, and with 3 vials you save €15 per vial compared to a single purchase.
Temperature-controlled refrigerated transport. Free shipping from €250, delivery in 5–9 business days.
Research details
10mg vial + 2 ml BAC water → concentration:
Per unit (10 IU)
0.50 mg
Steady-state plasma level after ~ 4 weeks with weekly administration.
Scientific references
